One of the most significant developments in laboratory medicine over the past few decades has been application of point-of-care testing (POCT). Technological advance allows an ever-increasing repertoire of in vitro diagnostic and monitoring tests to be performed outside the laboratory, at the patient’s bedside, in the ...

Arterial blood gases and other “acute care” biochemical blood tests are frequently ordered during recovery from cardiac arrest. Cardiac arrest, sudden loss of blood flow consequent on cessation of heart activity, is the ultimate medical emergency, frequently exploited for the dramatic nature of its presentation...

Decreased resources coupled with increased demand represents a major problem for healthcare providers that is most publicly manifest in overstretched hospital emergency room (ER) departments around the world. Prolonged waiting times and extended periods of overcrowding in ER, which are increasingly the norm, result in ...

Summary The reference interval for a biochemical analyte is usually an interval of values bounded by the reference limit values at certain designated percentiles [1].  As always when choosing a cut-off, the value will determine the trade-off between clinical sensitivity and specificity. When a low cut-off is chosen,...

This article first appeared in Pathology in Practice (Hobba H, Silver L. Evolution of POC testing. Pathology in Practice 2013; 14 [2]: 63) and is reproduced here by kind permission (www.pathologyinpractice.com). © 2013 kdm communications limited Point-of-care (POC) testing has allowed the pathology department in...

D-dimer testing can combined with assessment of pretest probability be used to rule out VTE in patients with a sufficiently low pretest probability of VTE. Patients with a negative D-dimer result can be ruled out, while patients with a positive D-dimer result need to have imaging performed for confirmatory diagnosis. ...

Point-of-care pathology testing is becoming increasingly common in hospitals, clinics and doctors’ offices; anywhere where time is critical and results are required at the patient’s side.  However, results must be accurate and reproducible to be meaningful, and it is imperative that a close eye is kept on...

Clinical biomarker studies seldom follow recommendations for the evaluation of new biomarkers. Therefore it is important to assess any published clinical value of a biomarker or comparison of two or more biomarkers and see whether or not the published study applies to your situation. If the published study does not...

A new parameter called critical reference change value (CrRCV) to be applied for the interpretation of serial measurements of cardiac troponin I (cTnI) is introduced. To illustrate the practical utility of CrRCV a set of clinical examples based on two consecutive cTnI results are presented. Thus three cTnI changes...

ROC curves are frequently used to show in a graphical way the connection/trade-off between clinical sensitivity and specificity for every possible cut-off for a test or a combination of tests. In addition the area under the ROC curve gives an idea about the benefit of using the test(s) in question.  ROC curves are...